ATE485052T1 - Kovalenter faktor vii-gewebefaktor-komplex - Google Patents

Kovalenter faktor vii-gewebefaktor-komplex

Info

Publication number
ATE485052T1
ATE485052T1 AT07727577T AT07727577T ATE485052T1 AT E485052 T1 ATE485052 T1 AT E485052T1 AT 07727577 T AT07727577 T AT 07727577T AT 07727577 T AT07727577 T AT 07727577T AT E485052 T1 ATE485052 T1 AT E485052T1
Authority
AT
Austria
Prior art keywords
factor
covalent
complex
factor vii
tissue
Prior art date
Application number
AT07727577T
Other languages
English (en)
Inventor
Henrik Ystergaard
Ole Olsen
Anders Klarskov Petersen
Henning Ralf Stennicke
Original Assignee
Novo Nordisk Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk Healthcare Ag filed Critical Novo Nordisk Healthcare Ag
Application granted granted Critical
Publication of ATE485052T1 publication Critical patent/ATE485052T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6437—Coagulation factor VIIa (3.4.21.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21021—Coagulation factor VIIa (3.4.21.21)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
AT07727577T 2006-04-07 2007-03-30 Kovalenter faktor vii-gewebefaktor-komplex ATE485052T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06112358 2006-04-07
PCT/EP2007/053105 WO2007115953A1 (en) 2006-04-07 2007-03-30 Covalent factor vii-tissue factor complex

Publications (1)

Publication Number Publication Date
ATE485052T1 true ATE485052T1 (de) 2010-11-15

Family

ID=36781437

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07727577T ATE485052T1 (de) 2006-04-07 2007-03-30 Kovalenter faktor vii-gewebefaktor-komplex

Country Status (8)

Country Link
US (1) US20110040073A1 (de)
EP (1) EP2007417B1 (de)
JP (1) JP5759102B2 (de)
CN (1) CN101466400B (de)
AT (1) ATE485052T1 (de)
DE (1) DE602007009956D1 (de)
ES (1) ES2353084T3 (de)
WO (1) WO2007115953A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2127640A1 (de) * 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Modifizierte azid-enthaltende Proteine
RU2531639C2 (ru) 2009-06-24 2014-10-27 Конинклейке Филипс Электроникс Н.В. Способ и устройство для программирования микроконтроллера
WO2011092242A1 (en) * 2010-01-28 2011-08-04 Novo Nordisk Health Care Ag Factor vii fusion polypeptides
WO2013143876A1 (en) * 2012-03-30 2013-10-03 Novo Nordisk A/S Fviia-stf complexes exhibiting exosite-mediated super activity
AU2013270682A1 (en) 2012-06-08 2014-12-11 Biogen Ma Inc. Procoagulant compounds
EP2863940A4 (de) 2012-06-08 2016-08-10 Biogen Ma Inc Chimäre gerinnungsfaktoren
JP2015532307A (ja) 2012-10-15 2015-11-09 ノヴォ・ノルディスク・ヘルス・ケア・アーゲー 凝固因子ｖｉｉポリペプチド
EP3334452A4 (de) * 2015-08-12 2019-04-17 Cell Machines, Inc. Verfahren und zusammensetzungen in verbindung mit gerinnungskomplexen mit langer halbwertszeit
PE20212262A1 (es) 2019-04-17 2021-11-29 Novo Nordisk As Anticuerpos biespecificos
CN114836503B (zh) * 2022-04-29 2023-08-25 江苏祈瑞医药科技有限公司 一组具有肝损伤保护作用的乳清蛋白肽、高f值寡肽及其制备方法和应用
CN116041537B (zh) * 2022-09-26 2025-09-19 山西博鑫生物科技有限公司 一种重组组织因子rhTF突变体及其应用
WO2025168826A1 (en) 2024-02-08 2025-08-14 Hemab Aps Methods of treating coagulopathy
CN117860874B (zh) * 2024-03-12 2024-07-02 正大天晴药业集团南京顺欣制药有限公司 重组人凝血因子VIIa的药物组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5788965A (en) * 1991-02-28 1998-08-04 Novo Nordisk A/S Modified factor VII
WO1997020939A1 (en) * 1995-12-01 1997-06-12 Genentech, Inc. TISSUE FACTOR - KUNITZ DOMAIN FUSION PROTEINS AS FACTOR VIIa INHIBITORS
DK0979281T3 (da) * 1997-05-02 2005-11-21 Genentech Inc Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele
EP1982732A3 (de) * 2000-02-11 2011-06-08 Bayer HealthCare LLC Faktor VII- oder VIIA-ähnliche Konjugate
US20030008820A1 (en) * 2001-03-27 2003-01-09 Massachusetts Institute Of Technology Methods and products related to FGF dimerization
ATE532858T1 (de) * 2001-09-27 2011-11-15 Novo Nordisk Healthcare Ag Menschliche gerinnungsfaktor-vii-polypeptide
WO2003029420A2 (en) * 2001-10-02 2003-04-10 Genentech, Inc. Apo-2 ligand variants and uses thereof
HK1080372A1 (zh) * 2002-05-01 2006-04-28 Schering Aktiengesellschaft 作为抗凝剂的新型组织因子目标抗体
EP1523504A2 (de) * 2002-07-12 2005-04-20 Novo Nordisk A/S Gewebe faktorbindende immunokonjugate die faktor viia enthalten
WO2005032581A2 (en) * 2003-10-07 2005-04-14 Novo Nordisk Health Care Ag Hybrid molecules having factor vii/viia activity

Also Published As

Publication number Publication date
WO2007115953A1 (en) 2007-10-18
EP2007417A1 (de) 2008-12-31
ES2353084T3 (es) 2011-02-25
CN101466400B (zh) 2014-06-25
JP2009532048A (ja) 2009-09-10
DE602007009956D1 (de) 2010-12-02
EP2007417B1 (de) 2010-10-20
US20110040073A1 (en) 2011-02-17
CN101466400A (zh) 2009-06-24
JP5759102B2 (ja) 2015-08-05

Similar Documents

Publication Publication Date Title
DE602007009956D1 (de) Kovalenter faktor vii-gewebefaktor-komplex
ATE453670T1 (de) Acrylierte hyaluronsäure
MY145652A (en) Process for the manufacture of dihydropteridinones
MX2011001679A (es) Derivados de flavina.
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
EP2647692A3 (de) Zusammensetzungen und Verfahren mit Serinproteasevarianten
TW200716646A (en) (S)-N-methylnaltrexone
CA119816S (en) Manikin chest shield
IN2012DN00580A (de)
MA33537B1 (fr) Anticorps anti-cdcp1 humanisés
EA200801912A1 (ru) Лечение рака
FR2883179B1 (fr) Comprime enrobe
MX2010010660A (es) Nuevos complejos de rutenio como catalizadores para reacciones de metatesis.
MY151973A (en) Cyclic depsipeptides
MX2009007436A (es) Derivados espirociclicos de acido tetronico.
EP2132013A4 (de) Durch biotemplating hergestellte dünne metallnanodrähte
PT2382198E (pt) Processos e intermediários para a preparação de um inibidor macrocíclico de protease do vhc
UA91053C2 (en) Inhibitors of cytosolic phospholipase a2
NZ601142A (en) Composition for improving brain function and method for improving brain function
DK2089433T3 (da) Behandling, der er rettet mod cathepsin S
ATE444990T1 (de) Spritzbare akustikmassen
GB0701103D0 (en) Software duplication
ATE486128T1 (de) Zusammensetzungen und verfahren zur erhöhung der produktion rekombinanter gamma-carboxylierter proteine
MX2010009953A (es) Compuesto ciclico y sal del mismo.
SG129432A1 (en) Automated generation of multi-dimensional structure activity and structure property relationships

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties